Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 84 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8440706

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted May 14, 2013 · Expires May 9, 2033

    granted
  2. US 8440679

    Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted
  3. US 8440652

    MST1 kinase inhibitors and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  4. US 8436187

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  5. AU 2012205809

    Phenethylsulfone isoindoline derivatives as inhibitors of PDE 4 and/or cytokines

    CELGENE CORP [CH] · Granted May 2, 2013 · Expires Apr 27, 2033

    granted
  6. US 8431154

    Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient

    TAKEDA GMBH · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  7. US 8431594

    Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  8. US 8426426

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  9. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  10. US 8426458

    Hepatitis C Virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  11. US 8426425

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  12. US 8426359

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted
  13. US 8420650

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  14. US 8420852

    Phospholipase A2 inhibitors and their use in treating neurological injury and disease

    The Regents of the University of California · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  15. US 8420678

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  16. US 8420596

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  17. US 8420816

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  18. US 8415368

    Acid secretion inhibitor

    Takeda Pharmaceutical Company Limited · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted
  19. US 8410133

    Aminopyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  20. US 8410112

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  21. US 8404852

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 26, 2013 · Expires Mar 21, 2033

    granted
  22. US 8399666

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  23. US 8399458

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  24. US 8399478

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted